Effect of a managed care disease management program on diabetes care

American Journal of Managed Care

Volumn 15, Issue 9, 2009, Pages 575-580

  McEwen, Laura N ^a   Hsiao, Victoria C ^a   Nota Kirby, Elizabeth M ^c   Kulpa, Gloria J ^c   Schmidt, Karen G ^c   Herman, William H ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c M CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOSYLATED HEMOGLOBIN; INFLUENZA VACCINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATION; FEMALE; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RETINA EXAMINATION; SYSTOLIC BLOOD PRESSURE; CONFIDENCE INTERVAL; DISEASE MANAGEMENT; HEALTH INSURANCE; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK; UNITED STATES;

AGED; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MANAGED CARE PROGRAMS; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; UNITED STATES;

EID: 70349432357     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Julius S, Majahalme S, Palatini R Antihypertensive treatment of patients with diabetes and hypertension. Am J Hypertens. 2001;14(11, pt 2):310S-316S. (Pubitemid 33033101)
2. Hansson L, Zanchetti A, Carruthers SG, et al; HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancer. 1998;351(9118):1755-1762.
3. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361(9374):2005-2016.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354(9178):602]. Lancet. 1998;352(9131):837- 853.
6. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144(7):465-474.
7. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775-1779. (Pubitemid 35340544)
8. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002;288(15):1909-1914. (Pubitemid 35168149)
9. Ward MM. Yankey JW, Vaughn TE, et al. Physician process and patient outcome measures for diabetes care: relationships to organizational characteristics. Med Care. 2004;42(9):840-850.
10. Mangione CM, Gerzoff RB, Williamson DF, et al; TRIAD Study Group.The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med. 2006;145(2): 107-116.
11. Selby JV, Swain BE, Gerzoff RB, et al; TRIAD Study Group. Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research Into Action for Diabetes (TRIAD). Med Care. 2007;45(12):1144-1153.
12. TRIAD Study Group.TheTranslating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care. 2002;25(2):386-389.
13. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven; 1998.